Roivant dis­con­tin­ues lung dis­ease drug; Bio-Thera, In­tas make biosim­i­lar deal

Plus, news about Cali­way Bio­phar­ma­ceu­ti­cals, Or­ca Bio, Al­ter­i­ty Ther­a­peu­tics and As­cen­t­age Phar­ma:

Roivant dis­con­tin­ues rare lung dis­ease drug: The ter­mi­na­tion, dis­closed in Roivant’s

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER